Klick Health's Klick Labs created a programmable device that simulates Parkinson's disease tremors in a bid to create empathy and study its effect on…

Allergan’s new "Toilet Talk" campaign seeks to normalize bowel health conversations—and the more candid, the better.

Valeant unveiled the sticker on its new psoriasis drug Siliq—and at $3,500 per month it’s the lowest for next-gen meds.

The FDA is ordering major label changes on pain meds codeine and tramadol that will affect dozens of companies.

UniQure's trailblazing gene therapy has met its end. After struggling for years with the ultraexpensive Glybera, the company is calling it quits on the…

It was destined to happen: Amgen has sued Sanofi and Regeneron, claiming their newly approved Dupixent infringes one of its antibody patents.

Pharma largely continued its price-hiking ways in 2016, and no wonder: The corresponding sales windfall equated to 100% of the industry’s overall earnings-per-…

Biogen's Spinraza raised eyebrows for a $750,000 first-year price, but rare disease medications are expensive, period. Check out this list.

After years of pumping up its wellness content, Condé Nast has launched a new pharma-focused division to spur its reader-targeting powers and drive more custom…

Marketing